Pérez-Villalobos Valeria, Vidal Roberto, Hermoso Marcela A, Bustamante Paula
Molecular and Cellular Microbiology Laboratory, Instituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Chile.
Programa de Microbiología y Micología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Chile.
Microb Cell. 2025 Jul 11;12:173-181. doi: 10.15698/mic2025.07.854. eCollection 2025.
Persister cells are a subpopulation of bacteria capable of surviving antibiotic treatments and are thought to contribute to disease chronicity and symptom relapse of chronic conditions. Crohn's disease (CD) is a multifactorial chronic inflammatory condition of the gastrointestinal tract, and adherent-invasive (AIEC) have emerged as a key contributor to its pathogenesis. AIEC can survive, replicate, and produce persister cells within macrophages; however, beyond the LF82 reference strain, little is known about the persistence phenotype and its variability among AIEC strains. In this study, the survival of two AIEC reference strains was analyzed following ciprofloxacin treatment, a fluoroquinolone antibiotic commonly used in CD therapy. In addition, four AIEC clinical isolates and two non-AIEC pathotypes were included for comparison. We investigated the roles of the resident antibiotic resistance plasmid, the stress response protein HtrA, and macrophage-induced persister formation. Our results revealed broad variability in persister cell formation among AIEC strains. Remarkably, the reference NRG857c strain exhibits a threateningly high-persistence phenotype, with persistence levels 200-fold higher than LF82 and certain clinical isolates. Neither the antibiotic resistance plasmid nor HtrA were required for this phenotype. Moreover, unlike LF82, NRG857c did not exhibit increased persistence following macrophage internalization. Overall, our findings demonstrate the presence of distinct persistence phenotypes among AIEC strains and identify NRG857c as a high-persistence variant. These observations underscore the need to consider bacterial persistence in the management of CD, particularly given the potential presence of AIEC strains with elevated persistence capabilities.
持留菌是一类能够在抗生素治疗中存活的细菌亚群,被认为与疾病的慢性化以及慢性病症状复发有关。克罗恩病(CD)是一种胃肠道多因素慢性炎症性疾病,黏附侵袭性大肠杆菌(AIEC)已成为其发病机制的关键因素。AIEC能够在巨噬细胞内存活、复制并产生持留菌;然而,除了LF82参考菌株外,对于AIEC菌株的持留表型及其变异性知之甚少。在本研究中,分析了两种AIEC参考菌株在环丙沙星治疗后的存活情况,环丙沙星是一种常用于CD治疗的氟喹诺酮类抗生素。此外,还纳入了四株AIEC临床分离株和两株非AIEC致病型进行比较。我们研究了固有抗生素耐药质粒、应激反应蛋白HtrA以及巨噬细胞诱导的持留菌形成的作用。我们的结果显示,AIEC菌株之间持留菌形成存在广泛的变异性。值得注意的是,参考菌株NRG857c表现出极高的持留表型,其持留水平比LF82和某些临床分离株高200倍。这种表型既不需要抗生素耐药质粒也不需要HtrA。此外,与LF82不同,NRG857c在被巨噬细胞内化后并没有表现出持留性增加。总体而言,我们的研究结果表明AIEC菌株中存在不同的持留表型,并将NRG857c鉴定为高持留变异株。这些观察结果强调了在CD管理中考虑细菌持留性的必要性,特别是考虑到可能存在具有较高持留能力的AIEC菌株。